Apath LLC - Company Review
Apath LLC - Company ReviewSummary
Apath LLC (Apath) is a technology licensing company that offers commercial applications of virology and viral genetics. The company develops diagnostic and therapeutic products used in the treatment of viral infections. It develops drugs for hepatitis-C virus and other RNA viruses, such as influenza, respiratory syncytial virus, and hemorrhagic fever virus. Apath offers technologies including 3'NTR infectious clone technology, highly permissive cell line technology, HCV full virus life cycle technology, HCV diagnostic technology, HCV intellectual property estate, and HCV research and development tools. The company also holds patents for its sequence of hepatitis -C virus genome and diagnostic and therapeutic uses such as nucleic acids comprising conserved 3 terminal sequence element of the hepatitis c virus, and methods for the detection of hepatitis c virus terminal 3 non-coding region, among others. Apath is headquartered in New York, the US.
This comprehensive company report of Apath LLC provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.